{"name":"NeurAxon Inc.","slug":"neuraxon-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNWW5hTTJSa1pVNWI2MFJPS1pnN1VPbXVYVy14ZVU5V0I0OFFUTFR0eXVqQktVMkhZU2ZzMXYtZ3Y5RW1NR09hRWJLVUlEV21XUW5ub0Y0dDBKV1ZERVg0MVZKamo1UmxvZjNYTDZUTnlmX1MzeDJVSmltU1dIOXJiQ2RsU1ptV1N6QVRZZExldmU3YnI3UXhfZmtfVDktZTZQRlZncEd3WjM2Tm5xTWJyMlA5UnR0cnlLXzlXdjV3ZWctNkxEZ0hXc0loSVQ3dw?oc=5","date":"2022-01-19","type":"pipeline","source":"businesswire.com","summary":"Expansion Therapeutics Appoints Gary Bridger, Ph.D., to Its Board of Directors - businesswire.com","headline":"Expansion Therapeutics Appoints Gary Bridger, Ph.D., to Its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNa3VwM1haQTQ0Y29PZTRhSkctUm9XTnRVNWlEMjk5VERjV1RER0x1SWlxMEV5RlhuLVQwOWZhWW5QZGVYLWlNbHhDRkV0Wk5IQXRIbUlTVGQxWjJnS0IwY29XZ09YaDhBcHU5UnRYbTk1c3ZmSFN2SFREaEtmQmdvcXlaUS15VTBzVGpNSnVNSDA5ZHBidXktalpB?oc=5","date":"2010-06-14","type":"pipeline","source":"Law Times News","summary":"Lawyers, U.S. firms filling Canada’s biotech void - Law Times News","headline":"Lawyers, U.S. firms filling Canada’s biotech void","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}